Hemoteq AG
🏢 View company profile →8Patents
8Active
8Granted
48Portfolio score
Filing activity: Oct 15, 2002 → Aug 15, 2012 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8679520B2 | Coating of stents for preventing restenosis | Human Necessities | 53 | Active |
| US8597720B2 | Medical product for treating stenosis of body passages and for preventing threatening restenosis | Human Necessities | 26 | Active |
| US8916227B2 | Coating of the entire surface of endoprostheses | Human Necessities | 14 | Active |
| US8784862B2 | Compounds and method for coating surfaces in a hemocompatible manner | Emerging Cross-Sectional Technologies | 4 | Active |
| US9192697B2 | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis | Human Necessities | 2 | Active |
| US9968573B2 | Endoprosthesis having and active substance coating | Human Necessities | 1 | Active |
| US11185614B2 | Balloon catheter coated with an anti-restenotic active ingredient and a molecular dispersion agent that promotes transport | Human Necessities | 0 | Active |
| US9522219B2 | Resorbable stents which contain a magnesium alloy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.